Zobrazeno 1 - 10
of 239
pro vyhledávání: '"John T Leppert"'
Autor:
Calyani Ganesan, I‐Chun Thomas, Maria E Montez‐Rath, Glenn M Chertow, John T Leppert, Alan C Pao
Publikováno v:
JBMR Plus, Vol 7, Iss 9, Pp n/a-n/a (2023)
ABSTRACT Patients with kidney stone disease are at higher risk for bone disease. Hypocitraturia is common in patients with kidney stone disease and a key risk factor for stone recurrence. In this retrospective cohort study, we sought to determine whe
Externí odkaz:
https://doaj.org/article/ef4e2a9a4e824f2484f0a5df3d6e38c0
Autor:
Calyani Ganesan, I-Chun Thomas, Shen Song, Andrew J Sun, Ericka M Sohlberg, Manjula Kurella Tamura, Glenn M Chertow, Joseph C Liao, Simon Conti, Christopher S Elliott, John T Leppert, Alan C Pao
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0220768 (2019)
ObjectiveThe American Urological Association guidelines recommend 24-hour urine testing in patients with urinary stone disease to decrease the risk of stone recurrence; however, national practice patterns for 24-hour urine testing are not well charac
Externí odkaz:
https://doaj.org/article/deb80cff7b2e4dffabef6b388483c7a4
Autor:
Jinhui Li, Zhengyi Deng, Simon John Christoph Soerensen, Linda Kachuri, Andres Cardenas, Rebecca E. Graff, John T. Leppert, Marvin E. Langston, Benjamin I. Chung
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract Exposure to ambient air pollution has significant adverse health effects; however, whether air pollution is associated with urological cancer is largely unknown. We conduct a systematic review and meta-analysis with epidemiological studies,
Externí odkaz:
https://doaj.org/article/06724a96884240748181d3023816ee3d
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146505 (2016)
Androgen receptor (AR) is expressed in normal murine and human kidneys of both genders, but its physiologic role is uncertain. Several studies showed loss of AR in renal cell carcinoma (RCC) in conjunction with increasing clinical stage and pathologi
Externí odkaz:
https://doaj.org/article/3177412e8e26452781cb5731a3fc8ebf
Autor:
Haiyan E. Liu, Meghah Vuppalapaty, Christian R. Hoerner, Colin P. Bergstrom, Michael Chiu, Clementine Lemaire, James Che, Amanpreet Kaur, Adam Dimmick, Sean Liu, Thomas J. Metzner, Menna Araya, Steve Crouse, Markus Sprenger-Haussels, Martin Schlumpberger, John T. Leppert, Siegfried Hauch, Elodie Sollier, Alice C. Fan
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Therapies for metastatic castration-resistant prostate cancer (mCRPC) include targeting the androgen receptor (AR) with androgen receptor inhibitors (ARIs) and prostate-specific membrane antigen (PSMA). Having the ability to detec
Externí odkaz:
https://doaj.org/article/f147876cb7db462d84fa5bc412a8c4d4
Autor:
Ted A. Skolarus, Sarah T. Hawley, Jane Forman, Anne E. Sales, Jordan B. Sparks, Tabitha Metreger, Jennifer Burns, Megan V. Caram, Archana Radhakrishnan, Lesly A. Dossett, Danil V. Makarov, John T. Leppert, Jeremy B. Shelton, Kristian D. Stensland, Jennifer Dunsmore, Steven Maclennan, Sameer Saini, Brent K. Hollenbeck, Vahakn Shahinian, Daniela A. Wittmann, Varad Deolankar, S. Sriram
Publikováno v:
Implementation Science Communications, Vol 5, Iss 1, Pp 1-13 (2024)
Abstract Background Many men with prostate cancer will be exposed to androgen deprivation therapy (ADT). While evidence-based ADT use is common, ADT is also used in cases with no or limited evidence resulting in more harm than benefit, i.e., overuse.
Externí odkaz:
https://doaj.org/article/edf770c1937947e5bba9b2a128e51551
Autor:
Alice Guan, Eduardo J. Santiago-Rodríguez, Benjamin I. Chung, Janet K. Shim, Laura Allen, Mei-Chin Kuo, Kathie Lau, Zinnia Loya, James D. Brooks, Iona Cheng, Mindy C. DeRouen, Dominick L. Frosch, Todd Golden, John T. Leppert, Daphne Y. Lichtensztajn, Qian Lu, Debora Oh, Weiva Sieh, Michelle Wadhwa, Matthew R. Cooperberg, Peter R. Carroll, Scarlett L. Gomez, Salma Shariff-Marco
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Patients diagnosed with low-risk prostate cancer (PCa) are confronted with a difficult decision regarding whether to undergo definitive treatment or to pursue an active surveillance protocol. This is potentially further complicate
Externí odkaz:
https://doaj.org/article/aabab07a25854885916d582e6006fec5
Autor:
Ted A. Skolarus, Jane Forman, Jordan B. Sparks, Tabitha Metreger, Sarah T. Hawley, Megan V. Caram, Lesly Dossett, Alan Paniagua-Cruz, Danil V. Makarov, John T. Leppert, Jeremy B. Shelton, Kristian D. Stensland, Brent K. Hollenbeck, Vahakn Shahinian, Anne E. Sales, Daniela A. Wittmann
Publikováno v:
Implementation Science Communications, Vol 2, Iss 1, Pp 1-16 (2021)
Abstract Background Men with prostate cancer are often treated with the suppression of testosterone through long-acting injectable drugs termed chemical castration or androgen deprivation therapy (ADT). In most cases, ADT is not an appropriate treatm
Externí odkaz:
https://doaj.org/article/b6afa2d9261f4c2c8d1d29864c3c98e6
Autor:
Alex M. Kasman, Bogdana Schmidt, Kyle Spradling, Charlene Chow, Rebecca Hunt, Mechele Wu, Alexa Sockol, Joseph Liao, John T. Leppert, Jay Shah, Simon L. Conti
Publikováno v:
Current Urology, Vol 15, Iss 3, Pp 176-180 (2021)
Abstract. Background:. Opioids are commonly prescribed after ureteroscopy. With an increasing adoption of ureteroscopy for management of urolithiasis, this subset of patients is at high risk for opioid dependence. We sought to pilot an opioid-free di
Externí odkaz:
https://doaj.org/article/26b7bb6a19864881a89281d9d3a72d27
Autor:
Carolyn D. Seib, Calyani Ganesan, Adam Furst, Alan C. Pao, Glenn M. Chertow, John T. Leppert, Insoo Suh, Maria E. Montez-Rath, Alex H.S. Harris, Amber W. Trickey, Electron Kebebew, Manjula Kurella Tamura
Publikováno v:
Annals of Internal Medicine. 176:624-631
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a865dc767d86f99b43e402eae36b2e8
https://doi.org/10.7326/m22-2222
https://doi.org/10.7326/m22-2222